BRITAIN-NEPAL_MEDICAL_TRU - Accounts


Charity Registration No. 255249
Company Registration No. 921566 (England and Wales)
BRITAIN-NEPAL MEDICAL TRUST
ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2020
BRITAIN-NEPAL MEDICAL TRUST
LEGAL AND ADMINISTRATIVE INFORMATION
Trustees
Dr G M C Holdsworth
Dr R P Dhital
Mr J W Mecaskey
Dr J M V Payne
Secretary
Dr M Maidrag
Charity number
255249
Company number
921566
Principal address
17 Church Road
Tunbridge Wells
Kent
TN1 1LG
Registered office
17 Church Road
Tunbridge Wells
Kent
TN1 1LG
Independent examiner
Tina Clay BA FCA
Foot Davson Ltd
17 Church Road
Tunbridge Wells
Kent
TN1 1LG
BRITAIN-NEPAL MEDICAL TRUST
CONTENTS
Page
Trustees' report
1 - 2
Independent examiner's report
3
Statement of financial activities
4
Balance sheet
6
Notes to the financial statements
7 - 15
BRITAIN-NEPAL MEDICAL TRUST
TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT)
FOR THE YEAR ENDED 31 DECEMBER 2020
- 1 -

The trustees present their report and financial statements for the year ended 31 December 2020.

The financial statements have been prepared in accordance with the accounting policies set out in note 1 to the financial statements and comply with the charity's [governing document], the Companies Act 2006 and "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)".

Objectives and activities

The overall goal of BNMT is the improvement in health and livelihood of marginalised and conflict affected communities living in remote and rural areas of Nepal. The organisation seeks to achieve this goal through working in partnership with BNMT Nepal, a local NGO established to support BNMT in delivery of a programme of work which includes: strengthening partners (local community groups and NGOs and local health workers); empowering communities for improved access to health services or advocating for such access; leading on innovation and advocating for mainstreaming of effective interventions.

The trustees have paid due regard to guidance issued by the Charity Commission in deciding what activities the charity should undertake.
Achievements and performance

BNMT’s support to the National Tuberculosis Programme (NTP) continues through its the laboratory quality assurance provision in the Eastern region. Other components of BNMT’s support to NTP have been transferred to our local partner organisation (BNMT Nepal) – however BNMT continues to provide financial and technical support to BNMT Nepal as part of BNMT’s long term vision and strategy for sustainability.

 

BNMT has been working collaboratively with the Royal Marsden Hospital NHS Trust and Institute of Cancer Research to support the development of oncology service in Nepal and inclusion in a global cancer research network. Our partnership with Bhaktapur Cancer Hospital and the Oncology department at Bir Hospital Kathmandu – continues to support a Nepal oncology network and development of an oncogenetics facility.

 

BNMT has worked with SH:24 CIC on a discovery phase of developing a pilot for remote testing for HPV. HPV is the main cause of cervical cancer – which is the biggest cancer killer of women in Nepal. SH:24 is the UK leading online specialist sex and reproductive health service in the UK and beyond. The work was supported in addition with a grant from Innovate UK.

 

 

 

Financial review

Unrestricted funds showed expenditure in excess of income of £95,987 (2019: £86,515), and an increase in the value of the investments of £6,738 (2019: £13,298). This gives an overall decrease in unrestricted funds of £89,249 (2019: 73,217), leaving a balance of £269,519 (2019: £358,768).

Restricted funds showed increase in £1,470 in 2020 (2019: deficit of £4,678), leaving a restricted balance of £8,965 (2019: £7,495) to be used in later periods.

The Directors aim to hold unrestricted reserves of between 3 and 6 months annual income as working capital. Investments held are medium term and are reviewed two times each year. The Trustees have ethical considerations when making decisions to ensure particularly that healthcare considerations are not compromised. Cash deposits are held at best interest rates commensurate with accessibility for cash flow purposes.

 

The trustees have assessed the major risks to which the charity is exposed, and are satisfied that systems are in place to mitigate exposure to the major risks.

BRITAIN-NEPAL MEDICAL TRUST
TRUSTEES' REPORT (CONTINUED)(INCLUDING DIRECTORS' REPORT)
FOR THE YEAR ENDED 31 DECEMBER 2020
- 2 -

The Directors have a risk management strategy which comprises the maintenance of a detailed risk register which is reviewed annually. Interim reviews have also been carried out to assess and adjust policies as necessary to take account of changing security concerns in Nepal and variations to emergency procedures.

Structure, governance and management

The charity was established as a charitable company limited by guarantee on 7th November 1967 (company number 921566). The company is registered with the Charity Commission (charity number 255249).

 

The Board of Trustees meets in the UK. The Charity's programme of activities is carried out in Nepal by Nepalese staff, under the direction of a Country Director.

The trustees, who are also the directors for the purpose of company law, and who served during the year and up to the date of signature of the financial statements were:

Dr G M C Holdsworth
Dr R P Dhital
Mr J W Mecaskey
Dr J M V Payne

New candidates for the Board are proposed by existing Trustees. Candidates receive written advice on the roles and responsibilities of Trustees and are invited to attend a Board meeting. Thereafter the Chair of the Board and the candidate exchange views and if appropriate the incoming Trustee is proposed, seconded and elected at the next Board meeting.

 

None of the trustees has any beneficial interest in the company. All of the trustees are members of the company and guarantee to contribute £1 in the event of a winding up.

The Board of Trustees is the final decision-making body. The Board is advised by a Finance & General Purposes Committee, composed of Trustees, the Country Director, the Company Secretary and Financial Adviser.

The trustees' report was approved by the Board of Trustees.

Dr G M C Holdsworth
Trustee
Dated: 26 August 2021
BRITAIN-NEPAL MEDICAL TRUST
INDEPENDENT EXAMINER'S REPORT
TO THE TRUSTEES OF BRITAIN-NEPAL MEDICAL TRUST
- 3 -

I report on the financial statements of the charity for the year ended 31 December 2020, which are set out on pages 4 to 15.

Respective responsibilities of trustees and examiner

As the charity trustees of the company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 (‘the 2006 Act’). The trustees consider that an audit is not required for the year under section 144(2) of the Charities Act 2011 (the 2011 Act) and that an independent examination is needed. The charity's gross income exceeded £250,000 and I am qualified to undertake the examination being a qualified member of the Institute of Chartered Accountants in England and Wales.

 

Having satisfied myself that the charity is not subject to audit under company law and is eligible for independent examination, it is my responsibility to:

(i)

examine the financial statements under section 145 of the 2011 Act;

(ii)
to follow the procedures laid down in the general Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act; and
(iii)
to state whether particular matters have come to my attention.
Basis of independent examiner's report

My examination was carried out in accordance with the general Directions given by the Charity Commission. An examination includes a review of the accounting records kept by the charity and a comparison of the financial statements presented with those records. It also includes consideration of any unusual items or disclosures in the financial statements, and seeking explanations from you as trustees concerning any such matters. The procedures undertaken do not provide all the evidence that would be required in an audit and consequently no opinion is given as to whether the financial statements present a ‘true and fair view’ and the report is limited to those matters set out in the next statement.

Independent examiner's statement

In connection with my examination, no matter has come to my attention:

(a)
which gives me reasonable cause to believe that in any material respect the requirements:
(i)

to keep accounting records in accordance with section 386 of the Companies Act 2006; and

(ii)

to prepare financial statements which accord with the accounting records, comply with the accounting requirements of section 396 of the Companies Act 2006 and with the methods and principles of the Statement of Recommended Practice: Accounting and Reporting by Charities;

have not been met or
(b)

to which, in my opinion, attention should be drawn in order to enable a proper understanding of the financial statements to be reached.

Tina Clay BA FCA
For and on behalf of
Foot Davson Ltd

Chartered Accountants

17 Church Road
Tunbridge Wells
Kent
TN1 1LG
Dated: 6 September 2021
BRITAIN-NEPAL MEDICAL TRUST
STATEMENT OF FINANCIAL ACTIVITIES
INCLUDING INCOME AND EXPENDITURE ACCOUNT
FOR THE YEAR ENDED 31 DECEMBER 2020
- 4 -
Unrestricted
Restricted
Total
Total
funds
funds
2020
2019
Notes
£
£
£
£
Income from:
Donations and legacies
2
31,990
1,470
33,460
52,297
Investments
3
78
-
78
259
Other income
4
24,086
-
24,086
5,976
Total income
56,154
1,470
57,624
58,532
Expenditure on:
Raising funds
5
13,199
-
13,199
10,110
Charitable activities
6
138,942
-
138,942
139,615
Total expenditure
152,141
-
152,141
149,725
(95,987)
1,470
(94,517)
(91,193)
Net (losses)/ gains on investments
10
6,738
-
6,738
13,298
Net movement in funds
(89,249)
1,470
(87,779)
(77,895)
Fund balances at 1 January 2020
358,768
7,495
366,263
444,158
Fund balances at 31 December 2020
269,519
8,965
278,484
366,263

The statement of financial activities includes all gains and losses recognised in the year.

All income and expenditure derive from continuing activities.

The statement of financial activities also complies with the requirements for an income and expenditure account under the Companies Act 2006.
BRITAIN-NEPAL MEDICAL TRUST
SUMMARY INCOME AND EXPENDITURE ACCOUNT
FOR THE YEAR ENDED 31 DECEMBER 2020
- 5 -
All income funds
2020
2019
£
£
Gross income
57,624
58,532
Gains on investments
6,738
13,298
Total income in the reporting period
64,362
71,830
Total expenditure from income funds
152,141
149,725
Net expenditure for the year
(87,779)
(77,895)
BRITAIN-NEPAL MEDICAL TRUST
BALANCE SHEET
AS AT 31 DECEMBER 2020
31 December 2020
- 6 -
2020
2019
Notes
£
£
£
£
Fixed assets
Tangible assets
11
259
467
Current assets
Debtors
13
9,948
6,531
Investments
88,730
81,992
Cash at bank and in hand
184,257
282,439
282,935
370,962
Creditors: amounts falling due within one year
14
4,710
5,166
Net current assets
278,225
365,796
Net assets
278,484
366,263
The funds of the charity:
Restricted income funds
16
8,965
7,495
Unrestricted income funds
269,519
358,768
278,484
366,263

The company is entitled to the exemption from the audit requirement contained in section 477 of the Companies Act 2006, for the year ended 31 December 2020.

 

Members have not required the company to obtain an audit of these accounts.

The trustees acknowledge their responsibilities for ensuring that the charity keeps accounting records which comply with section 386 of the Act and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its incoming resources and application of resources, including its income and expenditure, for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on
26 August 2021
26 August 2021
and are signed on its behalf by:
Dr G M C Holdsworth
Dr J M V Payne
Trustee
Trustee
Company Registration No. 921566
BRITAIN-NEPAL MEDICAL TRUST
NOTES TO THE  FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2020
- 7 -
1
Accounting policies
Company information

Britain-Nepal Medical Trust was established as a charitable company limited by guarantee on 7th November 1967 (company number 921566). The company is registered with the Charity Commission (charity number 255249).

1.1
Accounting convention

The accounts have been prepared in accordance with the charity's governing document, the Companies Act 2006 and “Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)” (as amended for accounting periods commencing from 1 January 2016). The charity is a Public Benefit Entity as defined by FRS 102.

 

The charity has taken advantage of the provisions in the SORP for charities applying FRS 102 Update Bulletin 1 not to prepare a Statement of Cash Flows.

The financial statements have departed from the Charities (Accounts and Reports) Regulations 2008 only to the extent required to provide a true and fair view. This departure has involved following the Statement of Recommended Practice for charities applying FRS 102 rather than the version of the Statement of Recommended Practice which is referred to in the Regulations but which has since been withdrawn.

The financial statements are prepared in sterling, which is the functional currency of the charity. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Going concern

At the time of approving the financial statements, the trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. Thus the trustees continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Charitable funds

Unrestricted funds are available for use at the discretion of the trustees in furtherance of their charitable objectives.

Restricted funds are subject to specific conditions by donors as to how they may be used. The purposes and uses of the restricted funds are set out in the notes to the financial statements.

1.4
Income
Income is recognised when the charity is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received.
Cash donations are recognised on receipt. Other donations are recognised once the charity has been notified of the donation, unless performance conditions require deferral of the amount. Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation.
Legacies are recognised on receipt or otherwise if the charity has been notified of an impending distribution, the amount is known, and receipt is expected. If the amount is not known, the legacy is treated as a contingent asset.
BRITAIN-NEPAL MEDICAL TRUST
NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2020
1
Accounting policies
(Continued)
- 8 -
1.5
Expenditure and irrecoverable VAT

Expenditure is recognised as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that settlement will be required and the amount of the obligation can be measured reliably.

All expenditure is accounted for on an accruals basis. All expenditure including support costs and governance costs are allocated or apportioned to the applicable expenditure headings.

 

Irrecoverable VAT is charged against the expenditure heading for which it was incurred.

 

Grants payable are payments to charities in Nepal, which are charged in the year when the grant is awarded by the Trustees.

1.6
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computers
25% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in net income/(expenditure) for the year.

1.7
Impairment of fixed assets

At each reporting end date, the charity reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

1.8
Cash and cash equivalents

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.9
Financial instruments

The trust only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of current asset investments which are subsequently measured at fair value with any gains or losses arising on remeasurement recognised in profit or loss.

1.10
Leases

Rentals payable under operating leases, including any lease incentives received, are charged as an expense on a straight line basis over the term of the relevant lease.

BRITAIN-NEPAL MEDICAL TRUST
NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2020
- 9 -
2
Donations and legacies
Unrestricted
Restricted
Total
Total
funds
funds
2020
2019
£
£
£
£
Donations and gifts
31,990
1,470
33,460
52,297
Unrestricted donations
31,990
42,297
Restricted donations
1,470
10,000
33,460
52,297
Donations and gifts
Young Dung
-
1,470
1,470
-
Angela Steele palliative care
-
-
-
10,000
Gift aided and other donations
31,990
-
31,990
42,297
31,990
1,470
33,460
52,297

 

3
Investment income
Unrestricted
Total
funds
2020
2019
£
£
Income from listed investments
-
112
Interest receivable
78
147
78
259

All investment income earned, during both this financial reporting period and the previous reporting period, was of an unrestricted nature.

4
Other income
2020
2019
£
£
Other income
24,086
5,976
BRITAIN-NEPAL MEDICAL TRUST
NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2020
4
Other income
(Continued)
- 10 -

All other income received, during both this financial reporting period and the previous reporting period, was of an unrestricted nature.

5
Raising funds
Unrestricted
Total
funds
2019
£
£
Cost of generating donations and legacies:
Publicity and fundraising
2,426
996
Annual Report
4,965
3,409

Accountancy

1,142
1,260
Consultants and professional services
1,465
1,388
Staff salaries
2,715
2,692
Depreciation
62
62
Office expenses
424
303
13,199
10,110
BRITAIN-NEPAL MEDICAL TRUST
NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2020
- 11 -
6
Charitable activities
Programme costs
Support costs
Gov'nce costs
Total
2019
£
£
£
£
£
Staff costs
-
1,810
4,525
6,335
6,280
Depreciation
-
42
104
146
146
Administration costs Nepal
-
-
-
-
2,316
Office expenses
-
535
577
1,112
817
Travel and Trustees expenses
-
-
-
-
807
Consultants and professional services
-
366
5,494
5,860
5,554
Independent examination fees
-
-
4,283
4,283
4,725
Accountancy
-
285
-
285
315
Net (profit) / loss on exchange
-
-
-
-
12
-
3,038
14,983
18,021
20,972
Grants payable (see note 7)
120,921
-
-
120,921
118,643
Total
120,921
3,038
14,983
138,942
139,615
Analysis by fund
Unrestricted funds
120,921
3,038
14,983
138,942
120,921
3,038
14,983
138,942
For the year ended 31 December 2019
Unrestricted funds
106,293
3,713
14,931
124,937
Restricted funds
14,678
-
-
14,678
120,971
3,713
14,931
139,615
7
Grants payable
2020
2019
£
£
Grants to BNMT Nepal
120,921
116,138
Grants to individuals
-
2,505
120,921
118,643
BRITAIN-NEPAL MEDICAL TRUST
NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2020
- 12 -
8
Trustees

None of the trustees (or any persons connected with them) received any remuneration during the year, but two of them were reimbursed a total of £807 travelling expenses (2019- one was reimbursed £56).

9
Employees
Number of employees

The average monthly number of employees during the year was:

2020
2019
Number
Number
1
1
Employment costs
2020
2019
£
£
Wages and salaries
2,715
2,692
10
Net gains/(losses) on investments
2020
2019
£
£
Revaluation of investments
6,738
13,298
6,738
13,298

All gains/(losses) on investments, during both this financial reporting period and the previous reporting period, related to unrestricted funds.

BRITAIN-NEPAL MEDICAL TRUST
NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2020
- 13 -
11
Tangible fixed assets
Computers
£
Cost
At 1 January 2020
831
At 31 December 2020
831
Depreciation and impairment
At 1 January 2020
572
At 31 December 2020
572
Carrying amount
At 31 December 2020
259
At 31 December 2019
467
12
Financial instruments
2020
2019
£
£
Carrying amount of financial assets
Instruments measured at fair value through profit or loss
88,730
81,992

Current asset investments are initially recognised at cost and are subsequently remeasured at fair value, being the quoted market price, with any gains or losses arising on remeasurement recognised in the SOFA.

At the year end the investments held had an original cost value of £8,706 (2019: £8,706) and a fair value (quoted market price) of £88,730 (2019: £81,992).

13
Debtors
2020
2019
Amounts falling due within one year:
£
£
Other debtors
9,948
6,531
BRITAIN-NEPAL MEDICAL TRUST
NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2020
- 14 -
14
Creditors: amounts falling due within one year
2020
2019
£
£
Other taxation and social security
-
133
Other creditors
-
33
Accruals and deferred income
4,710
5,000
4,710
5,166

 

15
Analysis of net assets between funds
Unrestricted funds

Restricted funds

Total
£
£
£
Fund balances at 31 December 2020 are represented by:
Tangible fixed assets
259
-
259
Current assets/(liabilities)
269,260
8,965
278,225
269,519
8,965
278,484
16
Restricted funds

The income funds of the charity include restricted funds comprising the following unexpended balances of donations and grants held on trust for specific purposes:

Movement in funds
Balance at 1 January 2020

Incoming resources

Resources expended
Balance at 31 December 2020
£
£
£
£
Angela Steele palliative care fund
7,495
-
-
7,495
Young Dung
-
1,470
-
1,470
7,495
1,470
-
8,965
BRITAIN-NEPAL MEDICAL TRUST
NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2020
- 15 -
17
Funds held as administrator
2020
2019
£
£
Funds held at 31st December
PDP Funders Group
148,027
17,186
The Institue of Cancer Research
8,617
5,932
156,644
23,118
The charity administers the above funds. These funds are not charity assets and are therefore
not included in the charity's financial statements.
2020-12-312020-01-01falseCCH SoftwareiXBRL Review & Tag 2020.39215662020-01-012020-12-31921566bus:Director12020-01-012020-12-31921566bus:Director42020-01-012020-12-31921566bus:Director52020-01-012020-12-31921566bus:Director62020-01-012020-12-31921566bus:CompanySecretary12020-01-012020-12-319215662020-12-319215662019-12-319215662019-01-012019-12-31921566bus:FRS1022020-01-012020-12-31921566bus:IndependentExaminationCharity2020-01-012020-12-31921566bus:FullAccounts2020-01-012020-12-31xbrli:purexbrli:sharesiso4217:GBP